[{"address1": "12265 El Camino Real", "address2": "Suite 350", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 727 1040", "fax": "858 614 7007", "website": "https://www.connectbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California.", "fullTimeEmployees": 81, "companyOfficers": [{"maxAge": 1, "name": "Dr. Wubin  Pan M.B.A., Ph.D.", "age": 58, "title": "Co-Founder, President & Chairman of the Board of Directors", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zheng  Wei Ph.D.", "age": 59, "title": "Co-Founder, CEO & Director", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven  Chan", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jiang  Bian J.D.", "title": "General Counsel & Chief Compliance Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lei  Sun Ph.D.", "age": 59, "title": "VP of Biologics & Head of CMC", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul  Collazo Ph.D.", "title": "VP & Global Head of Medical Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Malinda V.  Longphre Ph.D.", "title": "VP & Head of US Clinical Operations", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 1.33, "open": 1.3899, "dayLow": 1.32, "dayHigh": 1.4, "regularMarketPreviousClose": 1.33, "regularMarketOpen": 1.3899, "regularMarketDayLow": 1.32, "regularMarketDayHigh": 1.4, "beta": -0.603, "forwardPE": 2.5272727, "volume": 76226, "regularMarketVolume": 76226, "averageVolume": 166098, "averageVolume10days": 58970, "averageDailyVolume10Day": 58970, "ask": 1.4, "askSize": 100, "marketCap": 76593168, "fiftyTwoWeekLow": 0.535, "fiftyTwoWeekHigh": 2.84, "fiftyDayAverage": 1.4479, "twoHundredDayAverage": 1.165845, "currency": "USD", "enterpriseValue": -41647980, "floatShares": 16054360, "sharesOutstanding": 55103000, "sharesShort": 83144, "sharesShortPriorMonth": 107347, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0015, "heldPercentInsiders": 0.41263, "heldPercentInstitutions": 0.44043, "shortRatio": 0.38, "shortPercentOfFloat": 0.0027, "impliedSharesOutstanding": 55103000, "bookValue": 1.834, "priceToBook": 0.7579062, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -59503000, "trailingEps": -1.08, "forwardEps": 0.55, "enterpriseToEbitda": 0.648, "52WeekChange": 0.21929824, "SandP52WeekChange": 0.23099434, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CNTB", "underlyingSymbol": "CNTB", "shortName": "Connect Biopharma Holdings Limi", "longName": "Connect Biopharma Holdings Limited", "firstTradeDateEpochUtc": 1616160600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f1aecc10-79bf-31c7-a21a-8af27158e95e", "messageBoardId": "finmb_706016439", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.39, "targetHighPrice": 8.0, "targetLowPrice": 6.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 118704000, "totalCashPerShare": 2.154, "ebitda": -64233000, "totalDebt": 465000, "quickRatio": 4.892, "currentRatio": 4.986, "debtToEquity": 0.46, "returnOnAssets": -0.27071, "returnOnEquity": -0.46030998, "freeCashflow": -27069500, "operatingCashflow": -47930000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-01"}]